Jiangsu Lanfeng Bio-chemical (002513.SZ) predicts a net loss of 210 million to 290 million yuan in 2024.

19:31 20/01/2025

Blue Rich Chemical (002513.SZ) released its performance forecast for 2024, expecting the full-year attributable to the shareholders of the listed company to be...

Jiangsu Lanfeng Bio-chemical (002513.SZ) has released its performance forecast for the year 2024, expecting a net loss of 210 million to 290 million yuan for the full year attributable to the company's shareholders. During the reporting period, the company expects a net loss attributable to shareholders of the listed company, mainly due to a comprehensive review of various assets by the company and its subsidiaries at the end of the reporting period. Based on the principle of prudence, the company has made provisions for impairment of related assets with impairment indicators, including expected credit impairment losses and asset impairment losses, reducing the net profit attributable to shareholders of the listed company by approximately 68 million yuan for the current period.

MNSO (09896) spent $24.45 million to repurchase 55,600 shares on March 17th.

HK&S HOTELS (00045): In the fourth quarter of 2025, the average room revenue for The Peninsula Hotels in the Greater China region was 3428 Hong Kong dollars.

HK&S HOTELS (00045) releases its financial performance for the year 2025, with a profit attributable to shareholders of HK$320 million, reversing from a loss to a profit year-on-year.

MNSO (09896) spent $24.45 million to repurchase 55,600 shares on March 17th.

HK&S HOTELS (00045): In the fourth quarter of 2025, the average room revenue for The Peninsula Hotels in the Greater China region was 3428 Hong Kong dollars.

HK&S HOTELS (00045) releases its financial performance for the year 2025, with a profit attributable to shareholders of HK$320 million, reversing from a loss to a profit year-on-year.